Trial Details
Not RecruitingBasic Information
| Clinical ID | c5124 |
|---|---|
| Identifier | EUCTR2010-022215-19-GB |
| Trial Title | A Pharmacokinetic Study Of The Combined Use Of Recombinant Human GH And IGF-1 In Children With Inflammatory Bowel (Crohn) Disease .. - Combination rhGH + rhIGF-1 in childhood/adolescent Crohn |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Impaired growth in Paediatric Crohn's disease MedDRA version: 14.1.Level: LLT.Classification code 10011398.Term: Crohn's.System Organ Class: 100000004856.;Therapeutic area: Diseases [C] - Digestive System Diseas |
| Interventions | Trade Name: IncrelexProduct Name: Increlex 10mg/ml solution for injectionPharmaceutical Form: Solution for injectionINN or Proposed INN: Mecasermin [rDNA Origin] 10mg/ml solution CAS Number: 67763-96-6Other descriptive name: Recomb |
Participant Information
| Sponsor | Greater Glasgow & Clyde NHS |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |